In light of the accelerating journey towards data-driven medicines regulation this event aims to:
discuss data-enabled opportunities to improve medicines development and the EU;
inform and strengthen collaboration with stakeholders and partners on the delivery of the data activities included the network strategy to 2025 (workplan 2023-2025: HMA-EMA joint Big Data Steering Group).